entertainment -WSS

entertainment

author：knowledge 2025-10-04 04:01:19 - browse：35

Morgan Griffith -- health policy coverage from STAT — At a Wednesday hearing, Oversight subcommittee Chair Morgan Griffith (R-Va.) mocked Medicare drug price negotiation as “godfather mafia-style negotiation.” Anna Moneymaker/Getty Images

WASHINGTON — Republicans and Democrats fought it out over Medicare drug price negotiation Wednesday at a House hearing, with the former accusing the latter of setting up “mafia-style” theft of property.

Typically, intense hearings like the one before the House Energy and Commerce subcommittee take place when lawmakers are debating legislation, not well after a law passes.

Despite the popularity of Medicare drug price negotiation with voters in both parties, Republicans have attacked the law, known as the Inflation Reduction Act, since Democrats passed it last year. Republicans lawmakers and drugmakers say the drug pricing reforms included in the legislation, which empower Medicare to directly negotiate the prices of some medicines, are tantamount to government price setting and will lead to fewer new drugs. The industry is challenging the program as unconstitutional in multiple courts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

WSS

Flu vaccine offering decent levels of protection this winter, new data show

Live blog: Hearing on CRISPR

Life sciences investors close nearly $6 billion in new funds

What is microchimerism and how does it affect maternal health?

Lung cancer screening guidelines updated for cigarette smokers

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

entertainment

entertainment

entertainment

Anesthesiologist group: stop taking Ozempic before surgery

Inari Medical to buy amputation prevention company LimFlow

Cancer drug shortages should be causing more outrage

Explaining an after

In Memoriam: Notable people who died in 2023

Medicare must police algorithms in Medicare Advantage, Dems say

Duchenne breakthrough therapy leaves behind pioneering families

Medicare proceeds with plan to claw back hospital funds

The high cost of giving birth even with insurance

Biotech companies concerned about China biosecurity crackdown

focus

How to convince healthy people to buy insurance

Kenai launches with $82 million for Parkinson’s stem cell therapy

After Sarepta trial failure, Duchenne families brace for more debate

After Sarepta trial failure, Duchenne families brace for more debate

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

hotspot

focus

hotspot

focus